- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Medford Today
By the People, for the People
Pantoprazol Shows Promise in Blocking Tumor Growth
Repurposed Acid Reflux Drug May Influence Cancer Cell Electrical Activity
Published on Mar. 9, 2026
Got story updates? Submit your updates here. ›
Researchers have discovered that pantoprazol, a common medication used to treat acid reflux and heartburn, may hold promise as a potential cancer treatment. While still in early stages, studies suggest pantoprazol could act as an 'electrocêutical,' influencing the electrical activity of cancer cells and potentially hindering their proliferation.
Why it matters
The findings highlight the growing importance of understanding the role of bioelectricity in cellular behavior, including cancer cell growth. By manipulating the electrical properties of cancer cells, researchers aim to 'force' them to differentiate and slow down their uncontrolled proliferation.
The details
Traditionally, cancer research has focused on genetic mutations and biochemical pathways. However, a new frontier in cancer treatment is exploring the crucial role of electrical signaling in cellular behavior. The core idea behind electroceuticals is to modulate these electrical states, with the goal of 'forcing' cancer cells to differentiate and slow their growth. Pantoprazol, a proton pump inhibitor, may enhance the effects of other therapies used in this approach.
- The initial findings are based on laboratory studies with cancer cells, not clinical trials with patients.
The players
Michael Levin
A researcher at Tufts University who has spearheaded work highlighting the crucial role of electrical signaling in cellular behavior.
Federal University of Ceará (UFC)
A Brazilian university conducting research on nanocarriers to enhance the precision of drug delivery to tumor cells.
Instituto Nacional de Câncer (INCA)
The National Cancer Institute of Brazil, studying the interplay between metabolism and cancer.
What they’re saying
“The core idea behind electroceuticals is to modulate these electrical states. By manipulating the ion channels that control the flow of charged particles in and out of cells, researchers aim to 'force' cancer cells to differentiate, effectively slowing down or stopping their uncontrolled growth.”
— Michael Levin, Researcher
What’s next
Further research is needed to understand precisely how pantoprazol interacts with the electrical properties of cancer cells and whether it can be safely and effectively incorporated into a treatment regimen.
The takeaway
The potential of pantoprazol as a cancer therapy highlights the growing importance of understanding the role of bioelectricity in cellular behavior. By exploring the interplay between electrical signaling, metabolism, and cancer cell growth, researchers are opening up new avenues for innovative cancer treatments.
Medford top stories
Medford events
Mar. 13, 2026
Dancing with the CeltsMar. 14, 2026
The High Kings: The Rocky Road Tour




